IREDA FY26 Results: Net profit rises 10% YoY to ₹1,873 crore
IREDA posted a 10.3% YoY rise in FY26 net profit to ₹1,873.3 crore, buoyed by 23.4% revenue growth. The NBFC raised ₹2,005.9 crore via QIP and saw its CRAR improve to 20.59% following new RBI risk-weight norms, despite a rise in GNPA to 3.49%.

*this image is generated using AI for illustrative purposes only.
Indian Renewable Energy Development Agency Limited ( IREDA ) reported a 10.3% year-on-year increase in standalone net profit after tax (PAT) to ₹1,873.3 crore for the financial year ended March 31, 2026. Total income grew by 23.4% to ₹8,337.5 crore, driven primarily by a surge in interest income which rose 24.4% to ₹8,179.2 crore. The government-owned NBFC also recommended a final dividend of ₹0.55 per equity share, bringing the total dividend payout for the year to ₹1.15 per share.
Financial Performance Highlights
The lender’s profitability expanded despite higher financing costs and impairment provisions. Interest income, the primary revenue driver, increased from ₹6,575.4 crore in FY25 to ₹8,179.2 crore in FY26. However, finance costs also rose 18.4% to ₹4,904.7 crore, reflecting the expansion of its loan book. Impairment on financial instruments more than tripled to ₹777.1 crore from ₹237.2 crore in the previous year, indicating a prudent provisioning stance against credit risks.
| Metric | FY26 | FY25 | Change |
|---|---|---|---|
| Total Income | ₹8,337.5 crore | ₹6,754.8 crore | +23.4% |
| Net Profit After Tax | ₹1,873.3 crore | ₹1,698.6 crore | +10.3% |
| Interest Income | ₹8,179.2 crore | ₹6,575.4 crore | +24.4% |
| Finance Cost | ₹4,904.7 crore | ₹4,141.0 crore | +18.4% |
| Impairment Loss | ₹777.1 crore | ₹237.2 crore | +227.6% |
Capital Raise and Regulatory Updates
IREDA successfully completed Tranche I of its Qualified Institutional Placement (QIP), raising ₹2,005.9 crore by allotting 121.5 million equity shares at a premium of ₹155.14 per share. This capital infusion augmented the company’s capital base for onward lending and general corporate purposes. Following the issue, the Government of India’s shareholding stands at 71.76%. The Board has also approved a second QIP tranche of up to ₹2,994 crore, subject to shareholder approval.
Regulatory tailwinds supported the balance sheet strength. The company adopted the RBI’s revised risk-weight framework for high-quality infrastructure projects effective March 31, 2026. This adoption reduced risk-weighted assets by ₹7,787.8 crore and boosted the Capital to Risk (Weighted) Assets Ratio (CRAR) by 1.83 percentage points to 20.59%.
Asset Quality and Balance Sheet
The loan book expanded significantly, with total loans rising 21.4% to ₹90,196.6 crore from ₹74,271.5 crore in FY25. Gross Non-Performing Assets (GNPA) ratio increased to 3.49% from 2.45%, while Net NPA ratio remained stable at 1.29% compared to 1.30% in the prior year. The cumulative impairment allowance stood at ₹2,689.1 crore, with a provisioning coverage ratio of 2.88%.
Notably, certain accounts aggregating ₹394.0 crore are classified as Stage II (Standard) rather than Stage III (NPA) due to interim High Court orders. As a matter of prudence, interest income on these accounts is recognized on a collection basis. The company also reported two fraud cases amounting to ₹14.8 crore during the year, including an ongoing investigation into borrower group Gensol, against which adequate provisions have been made.
What the Numbers Show
A critical divergence exists between revenue growth and impairment costs. While interest income grew by 24.4%, impairment charges surged by 227.6% to ₹777.1 crore. This disproportionate rise in provisions suggests that asset quality management is consuming a larger share of operating profits than in previous years. Additionally, the QIP proceeds were fully utilized within the year, indicating aggressive deployment of fresh capital into the renewable energy lending pipeline.
Historical Stock Returns for IREDA
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.34% | -2.73% | -5.94% | -6.25% | -18.23% | +95.67% |
How will the tripling of impairment provisions impact IREDA's future credit growth strategy and risk appetite in the renewable energy sector?
What are the specific terms and timeline for the approved second QIP tranche of up to ₹2,994 crore, and how might it affect existing shareholder dilution?
Given the rise in GNPA to 3.49%, what measures is IREDA implementing to recover the ₹394 crore in Stage II accounts currently under High Court interim orders?


































